Related Experiment Video
Updated: Oct 15, 2025
08:56
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.8K
A case report: symptomatic pericarditis post-COVID-19 vaccination.
Sarah Ashaari1, Hafiz Ahmed Sohaib1, Kenneth Bolger1
1Department of Medicine, Tipperary University Hospital, Health Service Executive (HSE), Clonmel, Co. Tipperary E91 VY40, Ireland.
European Heart Journal. Case Reports
|October 25, 2021
Summary
Pericarditis is a rare side effect following the first dose of the Pfizer-BioNTech COVID-19 vaccine. While rare, the benefits of COVID-19 vaccination outweigh potential risks.
Area of Science:
- Cardiology
- Vaccinology
- Infectious Diseases
Background:
- The COVID-19 pandemic spurred rapid vaccine development.
- The CDC noted an increase in myopericarditis post-COVID-19 vaccination.
- Post-vaccination myopericarditis is an infrequent side effect.
Observation:
- A patient developed pericarditis 7 days after their first Pfizer-BioNTech COVID-19 vaccine dose.
- Symptoms included typical pericarditis signs with ECG and echocardiogram changes.
- Investigations ruled out other causes for the patient's condition.
Findings:
- The case presented is pericarditis after the first dose of the Pfizer-BioNTech COVID-19 vaccine.
- The patient experienced symptomatic relief with NSAIDs.
- Literature reports of post-vaccination pericarditis are limited.
Implications:
- While rare, pericarditis is a potential side effect of COVID-19 vaccination.
- The benefits of COVID-19 vaccination continue to outweigh the risks.
- Further research is needed to establish causality due to limited case numbers.
